Log In
Print this Print this

thrice-weekly glatiramer

  Manage Alerts
Collapse Summary General Information
Company Momenta Pharmaceuticals Inc.
DescriptionGeneric version of thrice-weekly Copaxone glatiramer, a selective major histocompatibility complex class II (MHCII) modulator
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing forms of multiple sclerosis (MS)
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today